When good transforming growth factor‐β turns bad in hepatocellular carcinoma: Axl takes the stage

E-ISSN： 1527-3350|61|3|759-761

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.3, 2015-03, pp. : 759-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 930-941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigenetic inactivation of transforming growth factor‐β1 target gene HEYL, a novel tumor suppressor, is involved in the P53‐induced apoptotic pathway in hepatocellular carcinoma

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 782-793

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transforming growth factor‐β and psoriasis: a new link

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1480-1481

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overexpression of Transforming Growth Factor-β1 in Scirrhous Carcinoma of the Stomach Correlates with Decreased Survival

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 582-587

Karger

Access to resources Recommend Favorite

Activation of the transforming growth factor‐β/SMAD transcriptional pathway underlies a novel tumor‐promoting role of sulfatase 1 in hepatocellular carcinoma

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1269-1283

John Wiley & Sons Inc

Access to resources Recommend Favorite